725 related articles for article (PubMed ID: 27061322)
81. Mass Spectrometry-Based Metabolomic and Proteomic Strategies in Organic Acidemias.
Imperlini E; Santorelli L; Orrù S; Scolamiero E; Ruoppolo M; Caterino M
Biomed Res Int; 2016; 2016():9210408. PubMed ID: 27403441
[TBL] [Abstract][Full Text] [Related]
82. Biomarkers and personalized therapy in chronic kidney diseases.
Schena FP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1051-4. PubMed ID: 24857812
[TBL] [Abstract][Full Text] [Related]
83. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
Patel S; Ahmed S
J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
[TBL] [Abstract][Full Text] [Related]
84. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
[TBL] [Abstract][Full Text] [Related]
85. Proteomics in Multiple Sclerosis: The Perspective of the Clinician.
Sandi D; Kokas Z; Biernacki T; Bencsik K; Klivényi P; Vécsei L
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563559
[TBL] [Abstract][Full Text] [Related]
86. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
Ribeiro HC; Zandonadi FDS; Sussulini A
Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
[TBL] [Abstract][Full Text] [Related]
87. Frontiers of high-throughput metabolomics.
Zampieri M; Sekar K; Zamboni N; Sauer U
Curr Opin Chem Biol; 2017 Feb; 36():15-23. PubMed ID: 28064089
[TBL] [Abstract][Full Text] [Related]
88. IntLIM: integration using linear models of metabolomics and gene expression data.
Siddiqui JK; Baskin E; Liu M; Cantemir-Stone CZ; Zhang B; Bonneville R; McElroy JP; Coombes KR; Mathé EA
BMC Bioinformatics; 2018 Mar; 19(1):81. PubMed ID: 29506475
[TBL] [Abstract][Full Text] [Related]
89. How can proteomics elucidate the complexity of multiple sclerosis?
Farias AS; Santos LM
Proteomics Clin Appl; 2015 Oct; 9(9-10):844-7. PubMed ID: 25980360
[TBL] [Abstract][Full Text] [Related]
90. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
91. Investigating the plant response to cadmium exposure by proteomic and metabolomic approaches.
Villiers F; Ducruix C; Hugouvieux V; Jarno N; Ezan E; Garin J; Junot C; Bourguignon J
Proteomics; 2011 May; 11(9):1650-63. PubMed ID: 21462346
[TBL] [Abstract][Full Text] [Related]
92. [The role of -omics technology in the pathophysiology, diagnosis, and treatment of cardiovascular diseases].
Sinan ÜY; Unlu S
Turk Kardiyol Dern Ars; 2017 Jul; 45(5):470-484. PubMed ID: 28694404
[TBL] [Abstract][Full Text] [Related]
93. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
94. Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine.
Kraniotou C; Karadima V; Bellos G; Tsangaris GT
J Proteomics; 2018 Sep; 188():59-62. PubMed ID: 29518575
[TBL] [Abstract][Full Text] [Related]
95. [Proteomics and personalized medicine].
Rocchiccioli S; Tedeschi L; Citti L; Cecchettini A
Recenti Prog Med; 2013 May; 104(5):189-99. PubMed ID: 23748691
[TBL] [Abstract][Full Text] [Related]
96. New technologies for biomarker discovery in multiple sclerosis.
Comabella M; Racke MK
J Neuroimmunol; 2012 Jul; 248(1-2):1. PubMed ID: 22726889
[No Abstract] [Full Text] [Related]
97. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
Pieragostino D; D'Alessandro M; di Ioia M; Di Ilio C; Sacchetta P; Del Boccio P
Proteomics Clin Appl; 2015 Feb; 9(1-2):169-86. PubMed ID: 25488355
[TBL] [Abstract][Full Text] [Related]
98. 18O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases.
Nemutlu E; Zhang S; Juranic NO; Terzic A; Macura S; Dzeja P
Croat Med J; 2012 Dec; 53(6):529-34. PubMed ID: 23275318
[TBL] [Abstract][Full Text] [Related]
99. Advancing single-cell proteomics and metabolomics with microfluidic technologies.
Liu Y; Chen X; Zhang Y; Liu J
Analyst; 2019 Jan; 144(3):846-858. PubMed ID: 30351310
[TBL] [Abstract][Full Text] [Related]
100. Toward a Taxonomy for Multi-Omics Science? Terminology Development for Whole Genome Study Approaches by Omics Technology and Hierarchy.
Pirih N; Kunej T
OMICS; 2017 Jan; 21(1):1-16. PubMed ID: 28271979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
